Project Details
| Short title | DM005001 |
|---|---|
| Status | Active |
| Effective start/end date | 9/12/24 → 9/09/26 |
CTU: A phase 1, multicenter, open-label, first-in-human, dose escalation and expansion study of DM005 in patients with advanced solid tumors
- Parsonson, Andrew (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research